Orbimed Advisors - ADAGIO THERAPEUTICS INC ownership

ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 83 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ADAGIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,959,680
+61.9%
5,270,4000.0%0.19%
+90.0%
Q2 2023$5,533,920
-12.5%
5,270,4000.0%0.10%
-19.4%
Q1 2023$6,324,480
-20.0%
5,270,4000.0%0.12%
-17.9%
Q4 2022$7,905,600
-52.1%
5,270,4000.0%0.15%
-50.7%
Q3 2022$16,496,000
-0.5%
5,270,400
+4.2%
0.31%
+2.0%
Q2 2022$16,584,000
-28.1%
5,056,0000.0%0.30%
-19.8%
Q1 2022$23,055,000
-36.3%
5,056,000
+1.5%
0.37%
-19.6%
Q4 2021$36,180,000
-84.1%
4,983,500
-7.4%
0.46%
-81.4%
Q3 2021$227,399,0005,383,5002.50%
Other shareholders
ADAGIO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 9,248,250$15,722,02518.03%
Alphabet Inc. 5,680,785$9,657,3340.62%
683 Capital Management, LLC 4,000,000$6,800,0000.53%
Bain Capital Life Sciences Investors, LLC 1,937,207$3,293,2520.37%
Acuitas Investments, LLC 208,579$354,5840.21%
MAVERICK CAPITAL LTD 5,270,290$8,959,4930.20%
Orbimed Advisors 5,270,400$8,959,6800.19%
Slate Path Capital LP 3,735,000$6,349,5000.18%
Redmile Group, LLC 1,440,725$2,449,2330.12%
TANG CAPITAL MANAGEMENT LLC 366,536$623,1110.09%
View complete list of ADAGIO THERAPEUTICS INC shareholders